PharmaCorp Closes Two Previously Announced Acquisitions and Provides Acquisition Pipeline Update
Acquisition of a PharmaChoice Canada-bannered pharmacy in Western Canada completed at a purchase price of $1,300,000, subject to customary post-closing adjustments The acquisition increases PharmaCorp’s operating network to 17 pharmacies Previously announced purchase of the prescription files of an I.D.A.-bannered pharmacy in Western Canada completed at a purchase price of $475,000, subject to customary post-closing adjustments Canadian Imperial Bank of Commerce acquisition facility increased by $10 million, from $17.5 million to $27.5 million, providing additional capacity to fund acquisitions Non-binding letter of intent executed for the proposed acquisition of three PharmaChoice Canada-bannered pharmacies in Atlantic Canada SASKATOON, Saskatchewan, Oct. 01, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“ PharmaCorp �� or the “ Corporation ”) (TSXV: PCRX), a Canadian pharmacy acquisition and ownership platform, announced today that, further to its August 18, 2026, news release, it has completed the acquisition of a 100 per cent interest in a PharmaChoice Canada-bannered pharmacy located in Western Canada (the “ Pharmacy Acquisition ”), pursuant to the previously disclosed share purchase agreement dated August 10, 2026.
